Stephen Machatha, Chief Development Officer at Aldeyra Therapeutics, Inc. (ALDX), sold 44,146 shares at $5.15 ($227K) on 2025-08-11, disclosed to the SEC on 2025-08-13.
Open-market sale of $227k ALDX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.15 | 22,073 | $114K | 50.0% |
| 2 | $5.15 | 22,073 | $114K | 50.0% |
| Total | $5.15 avg | 44,146 | $227K | 100% |
| Filing → |